BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1885775)

  • 21. Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock.
    Rodriguez-Wilhelmi P; Montes R; Matsukawa A; Nariuchi H; Hurtado V; Montes M; Hermida J; Rocha E
    J Lab Clin Med; 2003 Apr; 141(4):257-64. PubMed ID: 12677171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats].
    Zhu TJ; Dong GR; Huang GQ; Fan XP; Liu B; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):345-7. PubMed ID: 17456366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC
    Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anti-tumor necrosis factor-alpha monoclonal antibody in alleviating renal ischemia-reperfusion injury.
    Han SL; Yu LX; Ma JJ; Zeng FY; Liu XY; Sun XY; Shan HT; Yuan Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):332-4. PubMed ID: 12697466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
    Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
    J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.
    Lucas R; Heirwegh K; Neirynck A; Remels L; Van Heuverswyn H; De Baetselier P
    Immunology; 1990 Oct; 71(2):218-23. PubMed ID: 2228022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
    J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of ketamine on endotoxin-induced septic shock in rats and its mechanism].
    Xiao H; Xu HW; Liu H; Zhang L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 May; 19(5):303-5. PubMed ID: 17490574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
    Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
    Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection.
    Shi Y; Li HQ; Shen CK; Wang JH; Pan J; Qin SW; Liu R
    Pediatr Res; 1993 Sep; 34(3):345-8. PubMed ID: 8134178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
    Abraham E; Anzueto A; Gutierrez G; Tessler S; San Pedro G; Wunderink R; Dal Nogare A; Nasraway S; Berman S; Cooney R; Levy H; Baughman R; Rumbak M; Light RB; Poole L; Allred R; Constant J; Pennington J; Porter S
    Lancet; 1998 Mar; 351(9107):929-33. PubMed ID: 9734938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis.
    Romulo RL; Palardy JE; Opal SM
    J Infect Dis; 1993 Jan; 167(1):126-30. PubMed ID: 8418159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
    Rubin RM; Noland J; Rosenbaum JT
    Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The therapeutic effects of tumor necrosis factor-alpha monoclonal antibody on hepatopulmonary syndrome in rats].
    Zhao Z; Liu L; Liu N; Wu YL; Fu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):657-9, 662. PubMed ID: 20619089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.